Quarterly report pursuant to Section 13 or 15(d)

Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.19.2
Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 368 $ 1,711,197 $ (11,460,989) $ (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Stock based compensation expense   28,054 28,054
Issuance of warrants 304,395 304,395
Net income (loss) (1,412,686) (1,412,686)
Balance at Mar. 31, 2018 $ 368 2,043,646 (12,873,675) (10,829,661)
Balance, shares at Mar. 31, 2018 3,679,500      
Balance at Dec. 31, 2017 $ 368 1,711,197 (11,460,989) (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Net income (loss)         (4,128,941)
Balance at Jun. 30, 2018   $ 368 2,334,755 (15,589,930) (13,254,807)
Balance, shares at Jun. 30, 2018   3,679,500      
Balance at Mar. 31, 2018 $ 368 2,043,646 (12,873,675) (10,829,661)
Balance, shares at Mar. 31, 2018 3,679,500      
Stock based compensation expense 28,054 28,054
Issuance of warrants 263,055 263,055
Net income (loss)       (2,716,255) (2,716,255)
Balance at Jun. 30, 2018   $ 368 2,334,755 (15,589,930) (13,254,807)
Balance, shares at Jun. 30, 2018   3,679,500      
Balance at Dec. 31, 2018 $ 987 $ 20,152,107 $ (39,112,401) $ (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873
Stock based compensation expense $ 105,642 $ 105,642
Issuance of common stock upon exercise of Series A Warrants, net of issuance cost $ 42 2,172,638 2,172,680
Issuance of common stock upon exercise of Series A Warrants, net of issuance cost, shares 424,116      
Issuance of common stock as inducement to exercise Series A Warrants $ 51 (51)
Issuance of common stock as inducement to exercise Series A Warrants, shares 508,940      
Issuance of common stock upon exercise of Series B warrants $ 363 5,635,406 5,635,769
Issuance of common stock upon exercise of Series B warrants, shares 3,629,045      
Issuance of common stock upon exercise of Placement Agent Warrants 16,818 16,818
Issuance of common stock upon exercise of Placement Agent Warrants, shares 4,004      
Net income (loss) 500,213 500,213
Balance at Mar. 31, 2019 $ 1,443 $ 28,082,560 $ (38,612,188) $ (10,528,185)
Balance, shares at Mar. 31, 2019 14,436,978
Balance at Dec. 31, 2018 $ 987 $ 20,152,107 $ (39,112,401) $ (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873
Net income (loss)         $ 507,635
Balance at Jun. 30, 2019 $ 2,319 $ 39,590,292 $ (38,604,766) 987,845
Balance, shares at Jun. 30, 2019 4,268 23,186,931      
Balance at Mar. 31, 2019 $ 1,443 $ 28,082,560 $ (38,612,188) $ (10,528,185)
Balance, shares at Mar. 31, 2019 14,436,978
Stock based compensation expense $ 104,121 $ 104,121
Issuance of common stock upon exercise of Series B warrants $ 876 $ 7,732,587 $ 7,733,463
Issuance of common stock upon exercise of Series B warrants, shares 8,749,953
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants $ 3,671,024 $ 3,671,024
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants, shares 4,268      
Net income (loss) 7,422 7,422
Balance at Jun. 30, 2019 $ 2,319 $ 39,590,292 $ (38,604,766) $ 987,845
Balance, shares at Jun. 30, 2019 4,268 23,186,931